Ex-Insys Employee Pleads Guilty In U.S. Opioid Drug Probe

A former employee of Insys Therapeutics Inc pleaded guilty on Monday to having conspired to defraud insurers into paying for an expensive fentanyl-based drug that is at the heart of an investigation into the company. Elizabeth Gurrieri, a former manager of reimbursement services for Arizona-based Insys, entered her plea in federal court in Boston to one count of wire fraud conspiracy as part of deal to cooperate with U.S. authorities. Gurrieri’s cooperation could result in her testifying at a later trial of six ex-Insys executives and managers, including former Chief Executive Michael Babich, who prosecutors say participated in a scheme to bribe doctors to prescribe the drug, Subsys.